Alternative Treatments for Sumatriptan-Induced Nausea
For patients experiencing nausea with sumatriptan, alternative triptans such as rizatriptan, zolmitriptan, naratriptan, frovatriptan, almotriptan, or eletriptan should be tried, with non-oral formulations being particularly beneficial for those with significant nausea. 1
Alternative Triptan Options
- When sumatriptan causes nausea, switching to a different triptan is recommended, as patients who don't respond to or tolerate one triptan may respond well to another 1
- Non-oral routes of administration are particularly beneficial for patients with nausea:
Specific Triptan Characteristics to Consider
- Naratriptan (Amerge) has the longest half-life among triptans, which may decrease headache recurrence 1
- Frovatriptan (Frova) and almotriptan (Axert) reportedly have fewer adverse reactions than sumatriptan 1
- Eletriptan has been reported to have more rapid onset of action and fewer adverse reactions compared to sumatriptan 1, 3
Non-Triptan Alternatives
For mild to moderate migraines, NSAIDs are recommended as first-line therapy 1:
- Aspirin (650-1000mg)
- Ibuprofen
- Naproxen sodium
- Combination of acetaminophen, aspirin, and caffeine 1
Dihydroergotamine (DHE) nasal spray is appropriate for severe migraines and has good evidence for efficacy 1
- Contraindicated with triptans, pregnancy, and certain cardiovascular conditions 1
Managing Nausea as a Symptom
- Add an antiemetic medication when nausea is a significant component:
Important Clinical Considerations
- Try any new medication for 2-3 headache episodes before abandoning that line of therapy 1
- Match the characteristics of the drug with the patient's needs and usual headache duration 1
- For patients with significant nausea as part of their migraine syndrome, non-oral routes of administration should be prioritized 1, 2
Cautions and Contraindications
- All triptans share similar contraindications: ischemic vascular conditions, vasospastic coronary disease, uncontrolled hypertension, or significant cardiovascular disease 1
- Avoid using triptans within 24 hours of ergotamine derivatives 3
- Avoid using triptans with SSRIs or SNRIs due to risk of serotonin syndrome 3
Remember that epidemiological studies show that over 90% of migraine patients experience nausea during attacks, making this a common challenge in migraine management 2. The ability to administer treatment that bypasses the gastrointestinal tract can be particularly valuable for these patients.